eVisit Closes $45 Million in Series B Funding Round Led by Goldman Sachs Asset Management
Similar Posts
Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines
Curevo’s lead program is CRV-101, an adjuvanted subunit vaccine for shingles, which has demonstrated robust immunogenicity and tolerability in…
HealthSnap Closes $25 Million Series B Funding Amidst Continued Triple Digit Growth of RPM and Chronic Care Management Platform
New investment is led by Sands Capital, with participation from Comcast Ventures, and follows enterprise health system expansions…
